期刊文献+

甲状腺激素水平正常的血糖控制不佳2型糖尿病患者促甲状腺激素水平与代谢相关脂肪性肝病的相关性分析 被引量:2

The correlation between the level of thyroid-stimulating hormone and metabolic associated fatty liver disease in euthyroid type 2 diabetes mellitus patients with poor glucose control
下载PDF
导出
摘要 目的探讨甲状腺激素水平正常的血糖控制不佳2型糖尿病(T2DM)患者促甲状腺激素(TSH)水平与代谢相关脂肪性肝病(MAFLD)的相关性。方法回顾性选取2015年1月至2019年12月于首都医科大学附属北京安贞医院内分泌代谢科住院的甲状腺激素水平正常的血糖控制不佳T2DM患者425例,根据腹部B超检查结果分为伴MAFLD组(210例)和不伴MAFLD组(215例)。比较各组一般资料及TSH、游离三碘甲状腺原氨酸、游离甲状腺素等代谢相关指标的差异。采用Logistic回归方法分析MAFLD发病的相关因素。结果伴MAFLD组体重指数、腰围、舒张压、血尿酸、三酰甘油水平均显著高于不伴MAFLD组,饮酒史比例、高密度脂蛋白胆固醇(HDL-C)水平均显著低于不伴MAFLD组,差异均有统计学意义(均P<0.05)。伴MAFLD组的TSH水平显著高于不伴MAFLD组,差异有统计学意义[1.8(1.2,2.6)mIU/L比1.5(1.1,2.1)mIU/L](Z=-3.25,P<0.01)。体重指数、TSH(比值比=1.292,95%置信区间:1.013~1.647)是甲状腺激素水平正常血糖控制不佳T2DM患者MAFLD发病的独立危险因素,HDL-C为独立保护因素(均P<0.05)。结论在甲状腺激素水平正常的T2DM患者中,TSH水平与MAFLD的发病风险呈正相关,应重视对该类患者TSH水平的检测,及早防治MAFLD。 Objective To investigate the correlation between the level of thyroid-stimulating hormone(TSH)and metabolic associated fatty liver disease(MAFLD)in euthyroid type 2 diabetes mellitus(T2DM)patients with poor glucose control.Methods From January 2015 to December 2019,totally 425 euthyroid T2DM patients with poor glucose control who were hospitalized in Department of Endocrinology and Metabolism,Beijing Anzhen Hospital,Capital Medical University were selected retrospectively.According to the results of abdominal ultrasonography,they were divided into the MAFLD group(210 cases)and non-MAFLD group(215 cases).The general data and the differences of related metabolic indexes such as TSH,free triiodothyronine(FT3),and free thyroxine(FT_(4))were compared between the two groups.Logistic regression method was used to analyze the related factors of MAFLD.Results The levels of body mass index,waist circumference,diastolic blood pressure,blood uric acid and triacylglycerol in the MAFLD group were significantly higher than those in the non-MAFLD group,and the proportion of drinking history and the level of high-density lipoprotein cholesterol(HDL-C)were significantly lower than those in the non-MAFLD group(all P<0.05).The TSH level in the MAFLD group was significantly higher than that in the non-MAFLD group[1.8(1.2,2.6)mIU/L vs 1.5(1.1,2.1)mIU/L](Z=-3.25,P<0.01).Body mass index and TSH(odds ratio=1.292,95%confidence interval:1.013-1.647)were independent risk factors for MAFLD in euthyroid T2DM patients with poor glucose control,and HDL-C was an independent protective factor(all P<0.05).Conclusions In euthyroid T2DM patients,the level of TSH is positively correlated with the risk of MAFLD.Attention should be paid to the detection of TSH level in these patients to prevent and treat MAFLD as early as possible.
作者 苗艳菊 李涛涛 赵一楠 陶红 Miao Yanju;Li Taotao;Zhao Yinan;Tao Hong(Department of Endocrinology and Metabolism,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China;Department of Rheumatology and Immunology,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处 《中国医药》 2023年第4期526-530,共5页 China Medicine
基金 国家自然科学基金(81900448) 北京市卫生系统高层次卫生技术人才培养计划(2013-3-008) 首都卫生发展科研专项(首发2014-2-1064) 中华国际医学交流基金(Z-2017-26-1902)。
关键词 2型糖尿病 代谢相关脂肪性肝病 促甲状腺激素 甲状腺功能 Type 2 diabetes mellitus Metabolic associated fatty liver disease Thyroid-stimulating hormone Thyroid function
  • 相关文献

参考文献9

二级参考文献121

共引文献3923

同被引文献17

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部